Dissemin is shutting down on January 1st, 2025

Published in

American Chemical Society, ACS Chemical Neuroscience, 1(5), p. 71-80, 2013

DOI: 10.1021/cn4001878

Links

Tools

Export citation

Search in Google Scholar

Mitigation of ROS Insults by Streptomyces Secondary Metabolites in Primary Cortical Neurons

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Oxidative stress is a common point in neurodegenerative diseases, widely connected with mitochondrial dysfunction. In this study we screened seven natural products from Streptomyces sources against hydrogen peroxide insult in primary cortical neurons, an oxidative stress in vitro model. We showed the ability of these compounds to inhibit neuronal cytotoxicity and to reduce ROS release after 12 hours treatment. Among the tested compounds the quinone anhydroexfoliamycin and the red pyrrole-type pigment undecylprodigiosin stand out. These two compounds displayed the most complete protection against oxidative stress with mitochondrial function improvement, ROS production inhibition and increase of antioxidant enzymes levels, glutathione and catalase. Further investigations confirmed that anhydroexfoliamycin acts over Nrf2-ARE pathway, as a Nrf2 nuclear translocation inductor, and is able to strongly inhibit the effect of the mitochondrial uncoupler FCCP over cytosolic Ca2+ pointing to mitochondria as a cellular target for this molecule. In addition, both comounds were able to reduced caspase-3 activity induced by the apoptotic enhancer taurosporine, but undecylprodigiosin failed to inhibit FCCP effects and it did not act over Nrf2 pathway as was the case for anhydroexfoliamycin. These results show that Streptomyces metabolites could be useful for the development of new drugs for prevention of neurodegenerative disorders such as Parkinson's and Alzheimer's disease and cerebral ischemia.